Barriers to acceptance of controlled phase III clinical trials: behavioral factors.
Certain behavioral characteristics of physicians have traditionally lead to erroneous therapeutic observations. Appropriately designed clinical trials overcome behavioral pitfalls to insure a scientific (hence, ethical) result.